![Arthur A. Vandenbark](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Arthur A. Vandenbark
Founder at Artielle ImmunoTherapeutics, Inc.
Arthur A. Vandenbark active positions
Companies | Position | Start | End |
---|---|---|---|
Artielle ImmunoTherapeutics, Inc.
![]() Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Founder | 2003-12-31 | - |
Corporate Officer/Principal | 2003-12-31 | - | |
Oregon Health & Science University Foundation
![]() Oregon Health & Science University Foundation Miscellaneous Commercial ServicesCommercial Services Oregon Health & Science University Foundation exists to secure private philanthropic support for Oregon Health & Science University. The organization also invests and manages gifts from different donors. The OHSU Foundation also administers a separate grant-making program, the Medical Research Foundation awards, supporting biomedical research in Oregon by new investigators. It was founded in 1887 and is headquartered in Portland, OR. | Corporate Officer/Principal | - | - |
Career history of Arthur A. Vandenbark
Statistics
International
United States | 3 |
Operational
Corporate Officer/Principal | 2 |
Founder | 1 |
Sectoral
Health Technology | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Artielle ImmunoTherapeutics, Inc.
![]() Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | Health Technology |
Oregon Health & Science University Foundation
![]() Oregon Health & Science University Foundation Miscellaneous Commercial ServicesCommercial Services Oregon Health & Science University Foundation exists to secure private philanthropic support for Oregon Health & Science University. The organization also invests and manages gifts from different donors. The OHSU Foundation also administers a separate grant-making program, the Medical Research Foundation awards, supporting biomedical research in Oregon by new investigators. It was founded in 1887 and is headquartered in Portland, OR. | Commercial Services |
- Stock Market
- Insiders
- Arthur A. Vandenbark
- Experience